glp 1 drugs and menopause Women turn to weight loss in menopause: What to know about the benefits risks What Are GLP-1 Medications? A

Departments of Agriculture and Health and Human Services | AAFP, accessed April 22, 2025, Healthy diet - World Health Organization (WHO), accessed April 22, 2025, 2015-2020 Dietary Guidelines for Americans - Office of the Assistant Secretary for Health, accessed April 22, 2025, Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss

nonetheless, significant factors must be considered for patient selection and monitoring

In clinical trials, nausea affected roughly 44% of people taking Wegovy and up to 30-40% of tirzepatide users at higher doses

Real-world GLP-1 RA therapy in type 2 diabetes: a long-term effectiveness observational study

Yet prescribing patterns indicate these recommendations have not yet fully penetrated clinical practice